112 related articles for article (PubMed ID: 7858806)
1. Nimodipine.
Whitfield PC; Pickard JD
Br J Hosp Med; 1994 Nov 16-Dec 13; 52(10):539-40. PubMed ID: 7858806
[TBL] [Abstract][Full Text] [Related]
2. Nimodipine for delayed cerebral ischaemia after subarachnoid haemorrhage.
Drug Ther Bull; 1992 Oct; 30(21):81-3. PubMed ID: 1425221
[No Abstract] [Full Text] [Related]
3. Nimodipine in subarachnoid hemorrhage.
DiPalma JR
Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
[TBL] [Abstract][Full Text] [Related]
4. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
Brown G; Carley S
Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
[TBL] [Abstract][Full Text] [Related]
5. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
6. Oral nimodipine and cerebral ischaemia following subarachnoid haemorrhage.
Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
Br J Clin Pract; 1990 Feb; 44(2):66-7. PubMed ID: 2200492
[No Abstract] [Full Text] [Related]
7. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists in the management of subarachnoid haemorrhage.
Robinson MJ; Teasdale GM
Cerebrovasc Brain Metab Rev; 1990; 2(3):205-26. PubMed ID: 2223432
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of delayed ischaemic dysfunction in patients with subarachnoid haemorrhage. An update.
Acta Neurochir Suppl (Wien); 1988; 45():1-55. PubMed ID: 3223377
[No Abstract] [Full Text] [Related]
10. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Di Mascio R; Marchioli R; Tognoni G
Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
[TBL] [Abstract][Full Text] [Related]
11. Effect of nimodipine on cerebral blood flow and cerebrovascular reactivity after subarachnoid haemorrhage.
Rasmussen G; Bergholdt B; Dalh B; Sunde N; Cold G; Voldby B
Acta Neurol Scand; 1999 Mar; 99(3):182-6. PubMed ID: 10100962
[TBL] [Abstract][Full Text] [Related]
12. Nimodipine and cerebral ischaemia following subarachnoid haemorrhage.
Br J Neurosurg; 1989; 3(5):529-31. PubMed ID: 2818845
[No Abstract] [Full Text] [Related]
13. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
van den Bergh WM; Mees SM; Rinkel GJ
Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
[No Abstract] [Full Text] [Related]
14. Nimodipine reduces morbidity, mortality after disruption of cerebral blood flow.
Carmody J; Lilly JK
W V Med J; 1990 Feb; 86(2):49-51. PubMed ID: 2408232
[TBL] [Abstract][Full Text] [Related]
15. [Our experience with using nimodipine in the treatment of ischemic complications after subarachnoid hemorrhage].
Danilewicz B; Czepko R; Zawiliński J; Betlej M
Neurol Neurochir Pol; 1991; 25(2):222-9. PubMed ID: 1922667
[TBL] [Abstract][Full Text] [Related]
16. Subarachnoid haemorrhage.
Dorsch NW
Med J Aust; 1991 Apr; 154(8):505-6. PubMed ID: 2017082
[No Abstract] [Full Text] [Related]
17. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage.
Tettenborn D; Dycka J
Stroke; 1990 Dec; 21(12 Suppl):IV85-9. PubMed ID: 2148037
[No Abstract] [Full Text] [Related]
18. Nimodipine and cerebral ischaemia following subarachnoid haemorrhage.
Davies C; Keogh A
Br J Neurosurg; 1990; 4(4):355. PubMed ID: 2222885
[No Abstract] [Full Text] [Related]
19. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
[TBL] [Abstract][Full Text] [Related]
20. Clinical experiences with nimodipine in cerebral ischemia.
Kakarieka A; Schakel EH; Fritze J
J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
